IGF2BP1 and Schnyder corneal dystrophy: Overexpression of IGF2BP1 in CD34+ cells from SCD and β-thalassemia patients significantly increased HbF expression, reduced the imbalance of α and β-like chains, and alleviated the severity of these diseases (Chambers et al. 2020) (Fig. 3C).